Advertisement

Fuel Economy for Growing Cells

Sophisticated 21st-century analyses of the signaling pathways that control cell growth have led researchers back to the seminal work of Otto Warburg, who discovered in the 1920s that tumor cells generate their energy in an unusual way—by switching from mitochondrial respiration to glycolysis. The advantage conferred by this metabolic switch is puzzling because mitochondrial respiration is a more efficient way to produce ATP. Vander Heiden et al. (p. 1029) review arguments that rapidly growing cells have critical metabolic requirements that extend beyond ATP and that a better understanding of these requirements may shed new light on the “Warburg effect” and ultimately lead to new therapies for cancer.

Abstract

In contrast to normal differentiated cells, which rely primarily on mitochondrial oxidative phosphorylation to generate the energy needed for cellular processes, most cancer cells instead rely on aerobic glycolysis, a phenomenon termed “the Warburg effect.” Aerobic glycolysis is an inefficient way to generate adenosine 5′-triphosphate (ATP), however, and the advantage it confers to cancer cells has been unclear. Here we propose that the metabolism of cancer cells, and indeed all proliferating cells, is adapted to facilitate the uptake and incorporation of nutrients into the biomass (e.g., nucleotides, amino acids, and lipids) needed to produce a new cell. Supporting this idea are recent studies showing that (i) several signaling pathways implicated in cell proliferation also regulate metabolic pathways that incorporate nutrients into biomass; and that (ii) certain cancer-associated mutations enable cancer cells to acquire and metabolize nutrients in a manner conducive to proliferation rather than efficient ATP production. A better understanding of the mechanistic links between cellular metabolism and growth control may ultimately lead to better treatments for human cancer.

Get full access to this article

View all available purchase options and get full access to this article.

References and Notes

1
Hsu P. P., Sabatini D. M., Cell 134, 703 (2008).
2
Deberardinis R. J., Lum J. J., Hatzivassiliou G., Thompson C. B., Cell Metab. 7, 11 (2008).
3
Warburg O., Posener K., Negelein E., Biochem. Z. 152, 319 (1924).
4
Warburg O., Science 123, 309 (1956).
5
Weinhouse S., Z. Krebsforsch. Klin. Onkol. Cancer Res. Clin. Oncol. 87, 115 (1976).
6
Fantin V. R., St-Pierre J., Leder P., Cancer Cell 9, 425 (2006).
7
Moreno-Sanchez R., Rodriguez-Enriquez S., Marin-Hernandez A., Saavedra E., FEBS J. 274, 1393 (2007).
8
A. L. Lehninger, D. L. Nelson, M. M. Cox, Principles of Biochemistry (Worth, New York, ed. 2, 1993).
9
Christofk H. R., et al., Nature 452, 230 (2008).
10
Izyumov D. S., et al., Biochim. Biophys. Acta 1658, 141 (2004).
11
Vander Heiden M. G., Chandel N. S., Schumacker P. T., Thompson C. B., Mol. Cell 3, 159 (1999).
12
Shaw R. J., et al., Proc. Natl. Acad. Sci. U.S.A. 101, 3329 (2004).
13
Lum J. J., et al., Cell 120, 237 (2005).
14
Hardie D. G., Nat. Rev. Mol. Cell Biol. 8, 774 (2007).
15
Possibly up to four NADPH molecules per glucose can be produced if the products of the pentose phosphate shunt are metabolized via the TCA cycle and malic enzyme or cytosolic isocitrate dehydrogenase 1 (IDH1) to generate two additional NADPH molecules.
16
DeBerardinis R. J., et al., Proc. Natl. Acad. Sci. U.S.A. 104, 19345 (2007).
17
Christofk H. R., Vander Heiden M. G., Wu N., Asara J. M., Cantley L. C., Nature 452, 181 (2008).
18
Hatzivassiliou G., et al., Cancer Cell 8, 311 (2005).
19
Sonveaux P., et al., J. Clin. Invest. 118, 3930 (2008).
20
Buzzai M., et al., Oncogene 24, 4165 (2005).
21
Engelman J. A., et al., Nat. Med. 14, 1351 (2008).
22
Vander Heiden M. G., et al., Mol. Cell. Biol. 21, 5899 (2001).
23
Ben-Haim S., Ell P., J. Nucl. Med. 50, 88 (2009).
24
Baysal B. E., et al., Science 287, 848 (2000).
25
Pollard P. J., Wortham N. C., Tomlinson I. P., Ann. Med. 35, 634 (2003).
26
Selak M. A., et al., Cancer Cell 7, 77 (2005).
27
Parsons D. W., et al., Science 321, 1807 (2008).
28
Bleeker F. E., et al., Hum. Mutat. 30, 7 (2009).
29
Yan H., et al., N. Engl. J. Med. 360, 765 (2009).
30
Thompson C. B., N. Engl. J. Med. 360, 813 (2009).
31
Yuneva M., Zamboni N., Oefner P., Sachidanandam R., Lazebnik Y., J. Cell Biol. 178, 93 (2007).
32
Wise D. R., et al., Proc. Natl. Acad. Sci. U.S.A. 105, 18782 (2008).
33
Gao P., et al., Nature 458, 762 (2009).
34
Bensaad K., et al., Cell 126, 107 (2006).
35
Chiaradonna F., et al., Oncogene 25, 5391 (2006).
36
Serrano M., Lin A. W., McCurrach M. E., Beach D., Lowe S. W., Cell 88, 593 (1997).
37
Granot D., Snyder M., Proc. Natl. Acad. Sci. U.S.A. 88, 5724 (1991).
38
Chen Z., Odstrcil E. A., Tu B. P., McKnight S. L., Science 316, 1916 (2007).
39
Gatenby R. A., Gillies R. J., Nat. Rev. Cancer 4, 891 (2004).
40
Gottschalk S., Anderson N., Hainz C., Eckhardt S. G., Serkova N. J., Clin. Cancer Res. 10, 6661 (2004).
41
Elstrom R. L., et al., Cancer Res. 64, 3892 (2004).
42
Nolop K. B., et al., Cancer 60, 2682 (1987).
43
Kondoh H., et al., Antioxid. Redox Signal. 9, 293 (2007).
44
Evans J. M., Donnelly L. A., Emslie-Smith A. M., Alessi D. R., Morris A. D., BMJ 330, 1304 (2005).
45
Calle E. E., Kaaks R., Nat. Rev. Cancer 4, 579 (2004).
46
Pollak M., Nat. Rev. Cancer 8, 915 (2008).
47
El-Maghrabi M. R., Pilkis S. J., J. Cell. Biochem. 26, 1 (1984).

(0)eLetters

eLetters is a forum for ongoing peer review. eLetters are not edited, proofread, or indexed, but they are screened. eLetters should provide substantive and scholarly commentary on the article. Embedded figures cannot be submitted, and we discourage the use of figures within eLetters in general. If a figure is essential, please include a link to the figure within the text of the eLetter. Please read our Terms of Service before submitting an eLetter.

Log In to Submit a Response

No eLetters have been published for this article yet.

Information & Authors

Information

Published In

Science
Volume 324 | Issue 5930
22 May 2009

Submission history

Published in print: 22 May 2009

Permissions

Request permissions for this article.

Acknowledgments

We thank A. Van den Abbeele (Department of Imaging, Dana-Farber Cancer Institute, Boston) for the FDG-PET image. We also thank K. D. Courtney, A. J. Shaywitz, and K. D. Swanson for thoughtful discussions and critical reading of the manuscript and the Damon Runyon Cancer Research Foundation for support (to M.G.V.H.). M.G.V.H. receives grant support from the National Cancer Institute (NCI) and NIH; L.C.C. receives grant support from the NIH; and C.B.T. receives grant support from the NCI, NIH, and Abramson Family Cancer Research Institute to study aspects of cancer cell metabolism. M.G.V.H., L.C.C., and C.B.T. hold patents related to the targeting of cancer cell metabolism and have financial interests in Agios Pharmaceuticals, a company that seeks to exploit alterations in cancer metabolism for novel therapeutics.

Authors

Affiliations

Matthew G. Vander Heiden
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Beth-Israel Deaconess Cancer Center and Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Lewis C. Cantley* [email protected]
Beth-Israel Deaconess Cancer Center and Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA.
Craig B. Thompson* [email protected]
Department of Cancer Biology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA.

Notes

*
To whom correspondence should be addressed: E-mail: [email protected]; [email protected]

Metrics & Citations

Metrics

Article Usage

Altmetrics

Citations

Cite as

Export citation

Select the format you want to export the citation of this publication.

Cited by

  1. Screening of Oral Squamous Cell Carcinoma Through Color Intensity-Based Textural Features, Cureus, (2024).https://doi.org/10.7759/cureus.56682
    Crossref
  2. Metabolic Adaptation and Cellular Stress Response As Targets for Cancer Therapy, The World Journal of Men's Health, 42, 1, (62), (2024).https://doi.org/10.5534/wjmh.230153
    Crossref
  3. Global research trends and prospects of cellular metabolism in colorectal cancer, World Journal of Gastrointestinal Oncology, 16, 2, (527-542), (2024).https://doi.org/10.4251/wjgo.v16.i2.527
    Crossref
  4. Targeting NAD+ Metabolism to Modulate Autoimmunity and Inflammation, The Journal of Immunology, 212, 7, (1043-1050), (2024).https://doi.org/10.4049/jimmunol.2300693
    Crossref
  5. Effect of hypoxia‑HIF‑1α‑periostin axis in thyroid cancer, Oncology Reports, 51, 4, (2024).https://doi.org/10.3892/or.2024.8716
    Crossref
  6. Glycolysis‑related lncRNA may be associated with prognosis and immune activity in grade II‑III glioma, Oncology Letters, 27, 5, (2024).https://doi.org/10.3892/ol.2024.14371
    Crossref
  7. Immune checkpoint inhibitors in metastatic melanoma therapy (Review), Medicine International, 4, 2, (2024).https://doi.org/10.3892/mi.2024.137
    Crossref
  8. Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K‑562 and colorectal HCT‑116 cancer cells, International Journal of Oncology, 64, 4, (2024).https://doi.org/10.3892/ijo.2024.5630
    Crossref
  9. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis, World Journal of Gastroenterology, 30, 7, (759-769), (2024).https://doi.org/10.3748/wjg.v30.i7.759
    Crossref
  10. Three-dimensional microfluidic cell culture device that generates chemical and oxygen gradients, Japanese Journal of Applied Physics, 63, 3, (03SP48), (2024).https://doi.org/10.35848/1347-4065/ad23a8
    Crossref
  11. See more
Loading...

View Options

Check Access

Log in to view the full text

AAAS ID LOGIN

AAAS login provides access to Science for AAAS Members, and access to other journals in the Science family to users who have purchased individual subscriptions.

Log in via OpenAthens.
Log in via Shibboleth.

More options

Register for free to read this article

As a service to the community, this article is available for free. Login or register for free to read this article.

Purchase this issue in print

Buy a single issue of Science for just $15 USD.

View options

PDF format

Download this article as a PDF file

Download PDF

Full Text

FULL TEXT

Media

Figures

Multimedia

Tables

Share

Share

Share article link

Share on social media